Inhibition of the activin receptor improves cardiac remodelling in the ercc1 mouse model of accelerated ageing

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Cellular Pathomechanisms of Cardiac Remodeling Drugs, Drug Targets ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by